Everything you need to know about treatment options for Type 1 and Type 2 Diabetes. Learn about the best medicines and the keep up with the latest research.
Starting this month, Eli Lilly and Company will donate at least 200,000 KwikPens® to three relief organizations – Americares, Direct Relief and
Health Canada has approved Invokana® (canagliflozin) as an adjunct to diet, exercise, and standard-of-care therapy, to reduce the risk of end-stage
The U.S. Food and Drug Administration has approved Trijardy™ XR to lower blood sugar in adults with Type 2 diabetes, along with diet and
The FDA has issued a safety alert for the weight management medicine Belviq, Belviq XR (lorcaserin) due to a possible increased risk of cancer with
Eli Lilly today announced plans to add two more cost-saving options to its suite of solutions for people who use Lilly insulin. The company plans to
French drugmaker, Sanofi SA announced on Tuesday that will stop pouring in money to research diabetes and cardiovascular (DCV). The news came from
Medically reviewed by Victor Nguyen, PharmD, MS on July 10, 2019 — Written by Helen Marshall, BPharm, MRPharmS. Republished with permission
Medically reviewed by Dena Westphalen, PharmD on July 30, 2019 — Written by Lindsay Slowiczek, PharmD. Republished with permission
The U.S. Food and Drug Administration (FDA) has approved Novo Nordisk’s new drug, Rybelsus® (semaglutide) tablets for adults with Type 2
Novartis AG’s Sandoz unit, the maker of ranitidine, or Zantac, a popular heartburn medication announced today it would halt global
Get a little dLife delivered to your inbox every week.
Leave this field empty if you’re human: